An expert panel made up of two advisory committees has voted overwhelmingly for the FDA to impose strict new limitations on the multi-billion dollar testosterone drug industry.
Visit our Low-T blog to read the full story!
About the Author
Erin P. Mullen Sala
Erin P. Mullen Sala concentrates her practice on a variety of medical malpractice cases including wrongful death, failure to diagnose, surgical and gynecological malpractice, brain damaged baby, nursing home negligence and medical products liability cases.
Erin earned her J.D. from Rutgers University School of LawCamden in 2008. In law school, she participated in various hands-on legal clinics, including the Children’s Justice Clinic and Domestic Violence Clinic.